ProtoKinetix, Inc.
PKTX
ProtoKinetix, Incorporated ( ProtoKinetix, we, us, our, or the Company ) is a research and development stage bio-technology company focused on scientific medical research of AFGPs (Anti-Freeze Glycoproteins) or anti-aging glycoproteins, trademarked as AAGPs . The Company has recently been in the process of directing major efforts to the practical side of commercial validation.
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$374K
▼ -8.1% YoY
Op. Margin
–
ROIC
–
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (TTM)
-$107K
▲ +39.3% YoY
Net Debt
-$524.00
Net Cash Position
Cash & Equiv.
$524.00
Continue Research
Peers
Pharmaceutical Preparations · Pick stocks to compare with PKTX
ProtoKinetix (PKTX) in two numbers
Questions about ProtoKinetix
Is ProtoKinetix a high-quality business?
ProtoKinetix scores 10 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 2 checks computed from SEC filings. Its best check is net debt at -$524, and its weakest is share count change at 335.9%. The Quality tab shows every check against its target.
Does ProtoKinetix (PKTX) pay a dividend?
No. ProtoKinetix (PKTX) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 4 Nov 2026 (period ending 31 Mar 2026), SEC. Price: last close 19 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in PKTX's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing PKTX
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.